Merck and Samsung Bioepis Enter Biosimilars Development and Commercialization Agreement

[Business Wire] – WHITEHOUSE STATION, N.J. & SEOUL, South Korea–(BUSINESSWIRE)– Merck, (NYSE: MRK) known as MSD outside the United States and Canada, and Samsung Bioepis Co., Ltd., entered into an agreement to develop … more

View todays social media effects on MRK

View the latest stocks trending across Twitter. Click to view dashboard

See who Merck is hiring next, click here to view